Episode 59
Biotech Hangout
00:00
The FDA Approves Immunotherapy for Bladder Cancer
The FDA approved a drug from pharing for bladder cancer, even though by the sounds of it, pharing can't really make the product due to some manufacturing challenges. It didn't sound like they were asking for additional clinical trials, but we kind of have to see how that plays out. I don't think I'd seen much efficacy data for the IL-15 superagamous monotherapy. They did go into patients that were supposedly refractory to BCG. That'd be a little bit hard to define and prove. There are a bunch of issues at play with that product.
Transcript
Play full episode
